{
    "moduleId": "module_08",
    "moduleTitle": "L1 Deep Dive: Advanced PHASE Applications",
    "passingScore": 80,
    "questions": [
        {
            "id": "q8_1",
            "question": "During the late perimenopausal transition (STRAW+10 Stage -2), what characterizes the 'Looping' hormonal pattern discussed in Advanced Profiling?",
            "options": [
                "Suppressed FSH levels with consistently high progesterone",
                "High FSH levels coupled with erratic, unpredictable spikes and drops in Estradiol (E2)",
                "Low FSH and low LH with stabilized testosterone",
                "A linear decline of both estrogen and cortisol simultaneously"
            ],
            "correctAnswer": 1,
            "explanation": "In late perimenopause, the feedback loop between the brain and ovaries becomes erratic, leading to high FSH levels that attempt to stimulate the ovaries, resulting in unpredictable and often symptomatic spikes and drops in Estradiol."
        },
        {
            "id": "q8_2",
            "question": "Which enzyme, produced by certain gut bacteria in the estrobolome, is responsible for deconjugating estrogen, allowing it to be reabsorbed into circulation?",
            "options": [
                "Alpha-amylase",
                "Lipoprotein lipase",
                "Beta-glucuronidase",
                "Aromatase"
            ],
            "correctAnswer": 2,
            "explanation": "Beta-glucuronidase is the key enzyme in the estrobolome that breaks the bond between estrogen and glucuronic acid, allowing the 'free' estrogen to be reabsorbed into the bloodstream instead of being excreted."
        },
        {
            "id": "q8_3",
            "question": "To overcome 'Anabolic Resistance' in post-menopausal women, what is the specific 'Leucine Threshold' required per meal to effectively trigger Muscle Protein Synthesis (MPS)?",
            "options": [
                "0.5 - 1.0 grams",
                "1.2 - 1.8 grams",
                "2.5 - 3.0 grams",
                "5.5 - 7.0 grams"
            ],
            "correctAnswer": 2,
            "explanation": "Due to decreased anabolic sensitivity, menopausal women require a higher concentration of the amino acid leucine (2.5-3.0g) per bolus of protein to activate the mTOR pathway and initiate muscle repair."
        },
        {
            "id": "q8_4",
            "question": "The 'Brain Energy Gap' mentioned in Neurological Stabilization refers to a 15-25% decline in the brain's ability to utilize which fuel source?",
            "options": [
                "Glucose",
                "Ketones",
                "Medium-chain triglycerides",
                "Amino acids"
            ],
            "correctAnswer": 0,
            "explanation": "Menopause triggers a bioenergetic shift where the brain's ability to metabolize glucose declines, leading to symptoms like brain fog and fatigue unless the brain adapts to use alternative fuels like ketones."
        },
        {
            "id": "q8_5",
            "question": "Post-menopausal cardiovascular risk increases significantly because the loss of estrogen leads to a decline in __________, which is essential for vasodilation and endothelial health.",
            "options": [
                "Homocysteine",
                "Nitric Oxide",
                "Low-Density Lipoprotein (LDL)",
                "Cortisol"
            ],
            "correctAnswer": 1,
            "explanation": "Estrogen stimulates the production of Nitric Oxide in the blood vessels; when estrogen drops, Nitric Oxide production decreases, leading to arterial stiffness and higher cardiovascular risk."
        },
        {
            "id": "q8_6",
            "question": "In the Adrenal-Ovarian Axis shift, which adrenal androgen becomes the primary precursor for peripheral conversion into estrone (E1) after the ovaries stop functioning?",
            "options": [
                "Aldosterone",
                "Androstenedione",
                "Melatonin",
                "Thyroxine"
            ],
            "correctAnswer": 1,
            "explanation": "Post-menopause, the adrenals take over as the primary source of steroid precursors, specifically androstenedione, which is converted into estrone in adipose tissue and other peripheral sites."
        },
        {
            "id": "q8_7",
            "question": "What is the physiological target for vaginal pH to maintain a healthy urogenital microbiome and prevent Genitourinary Syndrome of Menopause (GSM)?",
            "options": [
                "pH 3.8 - 4.5",
                "pH 5.5 - 6.0",
                "pH 7.0 - 7.5",
                "pH 8.5 - 9.0"
            ],
            "correctAnswer": 0,
            "explanation": "A healthy, acidic vaginal pH (3.8-4.5) is maintained by Lactobacillus species; when estrogen drops, pH rises, leading to the thinning of tissues and increased risk of infections."
        },
        {
            "id": "q8_8",
            "question": "According to the PHASE Roadmap, if a client is in a state of 'High Sympathetic Drive' (Stage 1), what is the priority intervention before introducing heavy resistance training?",
            "options": [
                "Intermittent Fasting for 16 hours",
                "High-Intensity Interval Training (HIIT)",
                "Nervous System Stabilization and Cortisol Modulation",
                "Aggressive Caloric Restriction"
            ],
            "correctAnswer": 2,
            "explanation": "The PHASE Roadmap dictates that we must 'Stabilize before we Optimize.' If a client is in a high-stress, high-cortisol state, adding high-intensity exercise can further deplete them; stabilization of the nervous system is the priority."
        },
        {
            "id": "q8_9",
            "question": "A 2023 meta-analysis cited in the course indicates that post-menopausal women have a higher prevalence of which specific lipid profile shift compared to pre-menopausal women?",
            "options": [
                "Decrease in total cholesterol",
                "Shift from small-dense LDL (Pattern B) to large-buoyant LDL (Pattern A)",
                "Shift from large-buoyant LDL (Pattern A) to small-dense LDL (Pattern B)",
                "Total disappearance of VLDL particles"
            ],
            "correctAnswer": 2,
            "explanation": "The hormonal shift of menopause typically causes a transition toward Pattern B LDL (small, dense particles), which are more pro-atherogenic and increase the risk of plaque formation in the arteries."
        },
        {
            "id": "q8_10",
            "question": "In the context of Integrated Case Management, which 'PHASE' pillar addresses the removal of endocrine disruptors and the support of Phase II liver detoxification?",
            "options": [
                "Pillar 1: Physical Activity",
                "Pillar 2: Hormonal Profiling",
                "Pillar 3: Alimentary & Environmental Clearance",
                "Pillar 4: Systemic Stabilization"
            ],
            "correctAnswer": 2,
            "explanation": "Pillar 3 (Alimentary & Environmental) focuses on clearing the 'toxic load' from both the diet (gut health) and the environment (endocrine disruptors) to ensure hormones are metabolized and excreted efficiently."
        }
    ]
}